The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Frequency and risk factors of potential drug interactions in breast cancer patients.
Fatma Acar
No relevant relationships to disclose
İbrahim Hakkı Dursun
No relevant relationships to disclose
Hakan Harputluoglu
No relevant relationships to disclose
Ali Yiğit
No relevant relationships to disclose
Mehmet Salih Kilic
No relevant relationships to disclose
Emin Tamer Elkiran
No relevant relationships to disclose